Uptake of HIV testing among pregnant women in Ontario: Results from the HIV seroprevalence study to June 2002 Robert S. Remis, Carol Swantee, Carol Major,

Slides:



Advertisements
Similar presentations
Números.
Advertisements

Trend for Precision Soil Testing % Zone or Grid Samples Tested compared to Total Samples.
Trend for Precision Soil Testing % Zone or Grid Samples Tested compared to Total Samples.
AGVISE Laboratories %Zone or Grid Samples – Northwood laboratory
Trend for Precision Soil Testing % Zone or Grid Samples Tested compared to Total Samples.
The Epidemiology of HIV/AIDS in the Republic of Trinidad/Tobago With special reference to Women and Children Robert K. Lee MB,ChB;MPH.
Reflection nurulquran.com.
EuroCondens SGB E.
Worksheets.
1 Impact of Changes in the Telephone Environment On RDD Telephone Surveys Mary Cay Murray Abt Associates Inc Erin Foster Abt Associates Inc Jessica Cardoni.
Multiplication X 1 1 x 1 = 1 2 x 1 = 2 3 x 1 = 3 4 x 1 = 4 5 x 1 = 5 6 x 1 = 6 7 x 1 = 7 8 x 1 = 8 9 x 1 = 9 10 x 1 = x 1 = x 1 = 12 X 2 1.
Division ÷ 1 1 ÷ 1 = 1 2 ÷ 1 = 2 3 ÷ 1 = 3 4 ÷ 1 = 4 5 ÷ 1 = 5 6 ÷ 1 = 6 7 ÷ 1 = 7 8 ÷ 1 = 8 9 ÷ 1 = 9 10 ÷ 1 = ÷ 1 = ÷ 1 = 12 ÷ 2 2 ÷ 2 =
Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.
By John E. Hopcroft, Rajeev Motwani and Jeffrey D. Ullman
How can we tailor the delivery of the TB/HIV package to IDU? David H.-U. Haerry European AIDS Treatment Group (European Community Advisory Board, Policy.
Add Governors Discretionary (1G) Grants Chapter 6.
CALENDAR.
HIV Positive Mothers and their Infants Enhanced Perinatal Surveillance and Texas HARS Data Elvia Ledezma, MPH Texas Department of State Health Services.
HIV Surveillance Report, 2001 Minnesota Department of Health HIV/AIDS Surveillance System Minnesota Department of Health HIV/AIDS Surveillance System.
1 1  1 =.
1  1 =.
First cases of AIDS identified.
Summative Math Test Algebra (28%) Geometry (29%)
Background Ethiopia: second populous country in Africa, 80 million
突破信息检索壁垒 -SciFinder Scholar 介绍
The basics for simulations
Network TV Scatter vs. Spot TV Cost Comparison A25-54 CPMs Q Q TVB Analysis of SQAD National and Local Market Cost Estimate Data 1 Updated.
1 FaCES Clinic and Evaluation A Collaborative Effort….
TCCI Barometer March “Establishing a reliable tool for monitoring the financial, business and social activity in the Prefecture of Thessaloniki”
VOORBLAD.
TCCI Barometer March “Establishing a reliable tool for monitoring the financial, business and social activity in the Prefecture of Thessaloniki”
Sexual Behaviors that Contribute to Unintended Pregnancy and Sexually Transmitted Infections, Including HIV Infection.
Progressive Aerobic Cardiovascular Endurance Run
Name of presenter(s) or subtitle Canadian Netizens February 2004.
Opportunities for Prevention & Intervention in Child Maltreatment Investigations Involving Infants in Ontario Barbara Fallon, PhD Assistant Professor Jennifer.
2011 WINNISQUAM COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=1021.
Before Between After.
Benjamin Banneker Charter Academy of Technology Making AYP Benjamin Banneker Charter Academy of Technology Making AYP.
2011 FRANKLIN COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=332.
Subtraction: Adding UP
1 Non Deterministic Automata. 2 Alphabet = Nondeterministic Finite Accepter (NFA)
Static Equilibrium; Elasticity and Fracture
Resistência dos Materiais, 5ª ed.
& dding ubtracting ractions.
Weekly Attendance by Class w/e 6 th September 2013.
HIV and Aging Kathleen K Casey, MD Director, AIDS Ambulatory Care Center Jersey Shore University Medical Center.
1 Non Deterministic Automata. 2 Alphabet = Nondeterministic Finite Accepter (NFA)
Schutzvermerk nach DIN 34 beachten 05/04/15 Seite 1 Training EPAM and CANopen Basic Solution: Password * * Level 1 Level 2 * Level 3 Password2 IP-Adr.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario Robert S. Remis MD Department.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario: Update to 2002 Robert S.
HIV infection among men who have sex with men in Ontario: Analysis by race/ethnicity Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring.
TESTING FOR HIV TO PREVENT MOTHER-INFANT TRANSMISSION POLICY CONSIDERATIONS ROBERT S. REMIS MD DEPARTMENT OF PUBLIC HEALTH SCIENCES, UNIVERSITY OF TORONTO.
Epidemiologic overview of HIV/AIDS in Ontario and Toronto: 2004 update Robert S. Remis MD, MPH, FRCPC, Maraki Fikre Merid BSc Ontario HIV Epidemiologic.
Using the detuned assay to determine HIV incidence in Ontario: Results and methodologic perspectives Robert S. Remis, Carol Major, Carol Swantee, Margaret.
Increasing HIV testing among pregnant women: Results from the Ontario HIV seroprevalence study Robert S. Remis, Carol Swantee, Maraki Fikre Merid, Robert.
Trends in HIV incidence in Ontario based on the detuned assay: Update to October 2000 Robert S. Remis, Carol Major, Carol Swantee, Margaret Fearon, Evelyn.
HIV infection among persons in Ontario infected through heterosexual contact Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit.
Trends in HIV incidence in Ontario based on the detuned assay: Update to December 2002 Robert S. Remis, Carol Major, Carol Swantee, Margaret Fearon, Robert.
Trends in HIV diagnoses in Ontario, 2000­2004 Robert S. Remis, Jane Njihia, Carol Swantee, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit,
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2004 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
Laboratory Enhancement Study: Using the detuned assay to determine HIV incidence in Ontario October 1999 – July 2000 Robert S. Remis, Carol Major, Carol.
The HIV epidemic in Ontario: 2004 update Robert S. Remis, MD, MPH, FRCPC Ontario HIV Epidemiologic Monitoring Unit Department of Public Health Sciences,
Marked increase in first-time HIV diagnoses in Ontario, 2002.
Uptake of HIV testing among pregnant women in Ontario: Results from the HIV seroprevalence study to December 2000 Robert S. Remis, Carol Major, Margaret.
The HIV epidemic in Ontario: An epidemiologic update Robert S. Remis, MD, MPH, FRCPC, Department of Public Health Sciences, University of Toronto Presentation.
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2003 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
Epidemiologic Update on the HIV Epidemic in Ontario
Presentation transcript:

Uptake of HIV testing among pregnant women in Ontario: Results from the HIV seroprevalence study to June 2002 Robert S. Remis, Carol Swantee, Carol Major, Margaret Fearon, Evelyn Wallace, Peggy Millson, Liviana Calzavara, Elizabeth Rea, Susan King, Marion Vermeulen, Elaine Whittingham and Robert Palmer Department of Public Health Sciences, University of Toronto; Laboratories Branch and Public Health Branch, Ontario Ministry of Health and Long Term-Care; Toronto Public Health; Hospital for Sick Children Ontario HIV Treatment Network, 4th Annual Research Day, Toronto, Ontario, November 28, 2002

Acknowledgments Central Public Health Laboratory, Ontario Ministry of Health and Long-Term Care Central Public Health Laboratory, Ontario Ministry of Health and Long-Term Care Keyi Wu, programming Keyi Wu, programming Mark Fisher, systems consulting and custom download Mark Fisher, systems consulting and custom download Prenatal Screening Evaluation Committee Prenatal Screening Evaluation Committee Frank McGee, co-ordinator Frank McGee, co-ordinator Janis Tripp, consultant Janis Tripp, consultant Funding Funding AIDS Bureau, Ontario Ministry of Health and Long-Term Care AIDS Bureau, Ontario Ministry of Health and Long-Term Care Bureau of HIV/AIDS, STD and TB, Health Canada Bureau of HIV/AIDS, STD and TB, Health Canada

Background : Ontario HIV seroprevalence study : Ontario HIV seroprevalence study (Coates et al), 0.23 / 1,000 February 1994: ACTG 076 showed ZDV reduced February 1994: ACTG 076 showed ZDV reduced mother-infant HIV transmission by 67% 1997: Modelled HIV prevalence, 0.70/1,000 and estimated uptake of prenatal HIV testing , 20–25% 1997: Modelled HIV prevalence, 0.70/1,000 and estimated uptake of prenatal HIV testing , 20–25%

Ontario HIV screening program Spring 1995: Advisory to physicians to consider HIV testing of pregnant women at increased HIV risk Spring 1995: Advisory to physicians to consider HIV testing of pregnant women at increased HIV risk August 1997: Committee formed to plan program August 1997: Committee formed to plan program December 1998: Minister announced program to offer HIV testing to all pregnant women December 1998: Minister announced program to offer HIV testing to all pregnant women January 1999: Promotional materials and requisitions sent to physicians January 1999: Promotional materials and requisitions sent to physicians September 2001: Memo included with prenatal test report to physicians who had not prescribed an HIV test September 2001: Memo included with prenatal test report to physicians who had not prescribed an HIV test

Study objectives Quantify and characterize HIV prevalence among women of childbearing age in Ontario Quantify and characterize HIV prevalence among women of childbearing age in Ontario Evaluate the Ontario universal HIV screening program Evaluate the Ontario universal HIV screening program

Data management Data extracted from LAByrinth (prenatal and HIV diagnostic databases) Data extracted from LAByrinth (prenatal and HIV diagnostic databases) Study period: January 3, 1999 to June 30, 2002 Study period: January 3, 1999 to June 30, 2002 Records from HIV prenatal database matched to records in Records from HIV prenatal database matched to records in HIV diagnostic database Matching allowed for different spelling and structure of Matching allowed for different spelling and structure of name (double-barrelled first and last names) and reversal of month/day in birth date Separate prenatal tests aggregated into episode equivalent to the gestation period; HIV uptake analysed for each pregnancy Separate prenatal tests aggregated into episode equivalent to the gestation period; HIV uptake analysed for each pregnancy

Data analysis Number of women tested at prenatal visit included: Number of women tested at prenatal visit included: Women for whom HIV test ordered on prenatal requisition, or tested though HIV diagnostic service Women for whom HIV test ordered on prenatal requisition, or tested though HIV diagnostic service Tests categorized as current or previous to pregnancy Tests categorized as current or previous to pregnancy Analysis in SAS of: Analysis in SAS of: Trends over time in proportion tested Trends over time in proportion tested Testing rates by health region and age group Testing rates by health region and age group HIV-positive women: number and rates by type of test, region and quarter HIV-positive women: number and rates by type of test, region and quarter

Number of pregnancies by health region January 1999 to June 2002 Number pregnancies Proportion Toronto Central East, other Southwest Central West Ottawa Eastern, other Northern N/A or OFP 130, ,237 64,171 76,455 37,696 40,215 31,649 2,045 27% 22% 13% 16% 8% 6% Total 491,072100%

HIV testing among pregnancies by timing of HIV test, Ontario Proportion of pregnancies (%)

HIV testing among pregnancies for selected health regions Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2 Quarter ( ) Proportion of pregnancies (%) Metro Toronto Central East, other Southwest Central West

HIV testing among pregnancies for selected health regions

Proportion of pregnancoes tested for HIV by health region, Quarter 2, %29,29238,352Total 76% 78% 72% 81% 82% 79% 70% 8,128 6,553 3,529 4,350 2,531 2,297 1, ,762 8,611 4,536 6,081 3,108 2,816 2, Toronto Central East, other Southwest Central West Ottawa Eastern, other Northern N/A or OFP Proportion tested HIV tested Number of pregs

Number of PHUs in each region by proportion tested for HIV, Quarter 2, % % 80-89%70-79%60-69% Total 832Northern 55Eastern, other 1Ottawa 761Central West Southwest 6 15 Central East, other 1Toronto Total PHUs Number of PHUs by proportion of HIV testing uptake 1 3

Number of HIV-positive pregnancies Previous HIV Current HIV Total HIV TOTAL

HIV-positive pregnancies by time of diagnosis and quarter Q Q Q Q Q Q Q By Quarter Number of pregnancies Current Previous

Interpretation Actual uptake of HIV testing is somewhat higher due to false non-matches (especially in anonymous and coded HIV testing) Actual uptake of HIV testing is somewhat higher due to false non-matches (especially in anonymous and coded HIV testing) Study does not indicate why HIV test uptake is less than ideal (qualitative research of pregnant women and physician survey have been done) Study does not indicate why HIV test uptake is less than ideal (qualitative research of pregnant women and physician survey have been done) Study does not indicate number of HIV-infected women undiagnosed Study does not indicate number of HIV-infected women undiagnosed Unlinked component of HIV seroprevalence study among women not HIV tested is (finally!) under way Unlinked component of HIV seroprevalence study among women not HIV tested is (finally!) under way

Conclusions 1 Critical to capture data from HIV diagnostic database as well as from prenatal database Critical to capture data from HIV diagnostic database as well as from prenatal database HIV testing increased from 40% to 50% from January to May 1999, with modest increase until September, 2001 HIV testing increased from 40% to 50% from January to May 1999, with modest increase until September, 2001 Impact of memo: from 60 to 76%! Impact of memo: from 60 to 76%! Important regional differences in HIV test uptake Important regional differences in HIV test uptake Over 3.5 years, 113 women identified as HIV-positive, 35 previously diagnosed, 78 newly diagnosed Over 3.5 years, 113 women identified as HIV-positive, 35 previously diagnosed, 78 newly diagnosed Data suggests more high risk pregnant women are being offered and accepting HIV testing Data suggests more high risk pregnant women are being offered and accepting HIV testing

Conclusions 2 According to model (not presented) According to model (not presented) Birth rate among diagnosed HIV-infected women is low Birth rate among diagnosed HIV-infected women is low ~40% of HIV-infected women undiagnosed at conception remain undiagnosed ~40% of HIV-infected women undiagnosed at conception remain undiagnosed An estimated 8-10 preventable mother-infant HIV transmissions occurred in 2001 An estimated 8-10 preventable mother-infant HIV transmissions occurred in 2001